We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cystoprostatectomy Eases Cancer Symptoms

By HospiMedica staff writers
Posted on 26 Jan 2006
A new study finds that radical cystoprostatectomy (CP) can help alleviate the symptoms associated with prostate cancer invasion into the bladder. More...


The study, conducted at the department of urology at the university of Texas M.D. Anderson Cancer Center (Houston, TX, USA), evaluated the effect of cystoprostatectomy in 38 patients with clinical T4 prostate cancer. Before surgery, 34 of the patients reported local symptoms, which included pain, hematuria, urinary urgency, pelvic pain, or bladder outlet obstruction. After the procedure was performed, only eight patients had local symptoms. Ultimately, the surgery rendered 30 of the patients free of local symptoms indefinitely.

Furthermore, the requirement for tube insertion to overcome urinary obstruction fell from 22 tubes in 13 patients before surgery to two tubes in two patients afterwards. Average time of tube indwelling also decreased from almost seven months before surgery to one month after surgery. There were no perioperative deaths. However, five patients suffered rectal injury, which was more common with patients who had radiation therapy. Approximately one in five patients required repeat surgery to correct problems brought about by the primary procedure.

"Symptomatic or tube-dependent patients who have bladder invasion by prostate cancer may benefit from surgery if they are medically fit for major surgery, and have adequate performance status and limited or no metastatic disease,” according to Dr. Louis L. Pisters and colleagues in the study, published in the November 2005 edition of the Journal of Urology.

Nevertheless, they added, "Patients with symptomatic bladder invasion by prostate cancer must be fully informed of the potential complications associated with CP, as well as the expected benefit from the extended relief of local symptoms.




Related Links:
M.D. Anderson Cancer Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.